Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 467786

Safe anti-ulcer peptide, (PL-14736, Pliva) in trial for inflammatory bowel disease, stable gastric pentadecapeptide BPC 157 can cure rats with short bowel syndrome complicated with ulcerative colitis


Sever, Marko; Kliček, Robert; Ilić, Spomenko; Dobrić, Ivan; Petrović, Igor; Filipović, Marinko; Barišić, Ivan; Radić, Božo; Bilić, Vide; Berkopić, Lidija et al.
Safe anti-ulcer peptide, (PL-14736, Pliva) in trial for inflammatory bowel disease, stable gastric pentadecapeptide BPC 157 can cure rats with short bowel syndrome complicated with ulcerative colitis // Abstracts of the 13th International conference on gastrointestinal research & 13th International conference on on ulcer research ; u: Journal of physiology and pharmacology / Sikirić, Predrag (ur.).
Krakow: Polish Physiological Society, 2009. str. 83-83 (predavanje, međunarodna recenzija, sažetak, znanstveni)


CROSBI ID: 467786 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Safe anti-ulcer peptide, (PL-14736, Pliva) in trial for inflammatory bowel disease, stable gastric pentadecapeptide BPC 157 can cure rats with short bowel syndrome complicated with ulcerative colitis

Autori
Sever, Marko ; Kliček, Robert ; Ilić, Spomenko ; Dobrić, Ivan ; Petrović, Igor ; Filipović, Marinko ; Barišić, Ivan ; Radić, Božo ; Bilić, Vide ; Berkopić, Lidija ; Brčić, Luka ; Brčić, Iva ; Kolenc, Danijela ; Seiwerth, Sven ; Sikirić, Predrag

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
Abstracts of the 13th International conference on gastrointestinal research & 13th International conference on on ulcer research ; u: Journal of physiology and pharmacology / Sikirić, Predrag - Krakow : Polish Physiological Society, 2009, 83-83

Skup
International conference on gastrointestinal research (13 ; 2009) ; International conference on on ulcer research (13 ; 2009)

Mjesto i datum
Split, Hrvatska, 10.-16.09.2009

Vrsta sudjelovanja
Predavanje

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
BPC 157; short bowel syndrome; ulcerative colitis

Sažetak
Aim. Stable gastric pentadecapeptide BPC 157 recovered short bowel sydrome in rats after massive small bowel resection, improved intestinal adaptation, villus height, crypt depth, and muscle thickness (and inner (circular) and/or outer (longitudinal) muscular layer)), induced weight gain in weight of normal healthy rats (Dig Dis Sci, 2008 in press). BPC 157 is a safe anti-ulcer peptide (PL-14736, Pliva) in trial for IBD, and wound therapy, no toxicology reported (Gastroenterology, 2005) that healed intestinal anastomosis and fistulas (Dig Dis Sci, 2008, J Pharm Sci, 2008). BPC 157 also prevented and reversed ulcerative colitis induced by cysteamine enema (J Physiol, 1999). However, BPC 157 was not tested after small bowel massive resection in rats with ulcerative colitis. Materials and methods. Small bowel resection. Throughtout a 4 week period we tested rats with escalating bowel syndrome and progressive weight loss that had only 20% of small bowel (Dig Dis Sci, 2008, in press). Ulcerative colitis. Cysteamine enema 400 mg/kg i.r., 1ml/rat. Ulcerative colitis+small bowel resection. Enema was applied at 10 min before surgery. BPC 157 medication. BPC 157 (10 µg, 10ng/kg i.p. or in drinking water) first application 30 min following surgery, last 24 h before sacrifice (7, 14, 21, 28 days). Results. Small bowel resection. The rats had an escalating bowel syndrome and progressive weight loss despite the fourfold muscle thickness increase and twofold villus height and crypt depth increase during the first week. BPC 157 groups recovery showed improved intestinal adaptation, villus height, crypt depth, and muscle thickness (and inner (circular) and/or outer (longitudinal) muscular layer)) additionally increased. The rats immediately gained weight, ultimately to the weight of normal healthy rats. Ulcerative colitis. Controls exhibited pertinent ulceration, initial weight loss, and then decreased weight gain. BPC 157 rats immediately gained weight, ultimately to the weight of normal healthy rats, and had consistently less ulcerations. Ulcerative colitis+small bowel resection. Ulcerative colitis significantly aggravated all these parameters. BPC 157 retained the same beneficial effects, decreased ulcerative colitis, improved intestinal adaptation, villus height, crypt depth, and muscle thickness (and inner (circular) and/or outer (longitudinal) muscular layer)) additionally increased, early weight gain, ultimately to the weight of normal healthy rats. Conclusion. In addition to the recovery of the rats with short bowel syndrome or ulcerative colitis, BPC 157 can cure rats with short bowel syndrome complicated with ulcerative colitis. Aim. Stable gastric pentadecapeptide BPC 157 recovered short bowel sydrome in rats after massive small bowel resection, improved intestinal adaptation, villus height, crypt depth, and muscle thickness (and inner (circular) and/or outer (longitudinal) muscular layer)), induced weight gain in weight of normal healthy rats (Dig Dis Sci, 2008 in press). BPC 157 is a safe anti-ulcer peptide (PL-14736, Pliva) in trial for IBD, and wound therapy, no toxicology reported (Gastroenterology, 2005) that healed intestinal anastomosis and fistulas (Dig Dis Sci, 2008, J Pharm Sci, 2008). BPC 157 also prevented and reversed ulcerative colitis induced by cysteamine enema (J Physiol, 1999). However, BPC 157 was not tested after small bowel massive resection in rats with ulcerative colitis. Materials and methods. Small bowel resection. Throughtout a 4 week period we tested rats with escalating bowel syndrome and progressive weight loss that had only 20% of small bowel (Dig Dis Sci, 2008, in press). Ulcerative colitis. Cysteamine enema 400 mg/kg i.r., 1ml/rat. Ulcerative colitis+small bowel resection. Enema was applied at 10 min before surgery. BPC 157 medication. BPC 157 (10 µg, 10ng/kg i.p. or in drinking water) first application 30 min following surgery, last 24 h before sacrifice (7, 14, 21, 28 days). Results. Small bowel resection. The rats had an escalating bowel syndrome and progressive weight loss despite the fourfold muscle thickness increase and twofold villus height and crypt depth increase during the first week. BPC 157 groups recovery showed improved intestinal adaptation, villus height, crypt depth, and muscle thickness (and inner (circular) and/or outer (longitudinal) muscular layer)) additionally increased. The rats immediately gained weight, ultimately to the weight of normal healthy rats. Ulcerative colitis. Controls exhibited pertinent ulceration, initial weight loss, and then decreased weight gain. BPC 157 rats immediately gained weight, ultimately to the weight of normal healthy rats, and had consistently less ulcerations. Ulcerative colitis+small bowel resection. Ulcerative colitis significantly aggravated all these parameters. BPC 157 retained the same beneficial effects, decreased ulcerative colitis, improved intestinal adaptation, villus height, crypt depth, and muscle thickness (and inner (circular) and/or outer (longitudinal) muscular layer)) additionally increased, early weight gain, ultimately to the weight of normal healthy rats. Conclusion. In addition to the recovery of the rats with short bowel syndrome or ulcerative colitis, BPC 157 can cure rats with short bowel syndrome complicated with ulcerative colitis.

Izvorni jezik
Engleski

Znanstvena područja
Temeljne medicinske znanosti, Kliničke medicinske znanosti



POVEZANOST RADA


Projekti:
108-1083570-3635 - Pentadekapeptid BPC 157 - daljnja istraživanja (Sikirić, Predrag, MZOS ) ( POIROT)
108-1080321-0389 - Utjecaj pentadekapeptida BPC 157 na ženski urogenitalni sustav (Vrčić, Hrvoje, MZOS ) ( POIROT)
108-1083570-3636 - Učinak BPC 157 na induciranu bilijarnu opstrukciju (Anić, Tomislav, MZOS ) ( POIROT)
108-1083570-3643 - Kvantitativna analiza i prijenos slike u patologiji (Seiwerth, Sven, MZOS ) ( POIROT)

Ustanove:
Medicinski fakultet, Zagreb


Citiraj ovu publikaciju:

Sever, Marko; Kliček, Robert; Ilić, Spomenko; Dobrić, Ivan; Petrović, Igor; Filipović, Marinko; Barišić, Ivan; Radić, Božo; Bilić, Vide; Berkopić, Lidija et al.
Safe anti-ulcer peptide, (PL-14736, Pliva) in trial for inflammatory bowel disease, stable gastric pentadecapeptide BPC 157 can cure rats with short bowel syndrome complicated with ulcerative colitis // Abstracts of the 13th International conference on gastrointestinal research & 13th International conference on on ulcer research ; u: Journal of physiology and pharmacology / Sikirić, Predrag (ur.).
Krakow: Polish Physiological Society, 2009. str. 83-83 (predavanje, međunarodna recenzija, sažetak, znanstveni)
Sever, M., Kliček, R., Ilić, S., Dobrić, I., Petrović, I., Filipović, M., Barišić, I., Radić, B., Bilić, V. & Berkopić, L. (2009) Safe anti-ulcer peptide, (PL-14736, Pliva) in trial for inflammatory bowel disease, stable gastric pentadecapeptide BPC 157 can cure rats with short bowel syndrome complicated with ulcerative colitis. U: Sikirić, P. (ur.)Abstracts of the 13th International conference on gastrointestinal research & 13th International conference on on ulcer research ; u: Journal of physiology and pharmacology.
@article{article, editor = {Sikiri\'{c}, P.}, year = {2009}, pages = {83-83}, keywords = {BPC 157, short bowel syndrome, ulcerative colitis}, title = {Safe anti-ulcer peptide, (PL-14736, Pliva) in trial for inflammatory bowel disease, stable gastric pentadecapeptide BPC 157 can cure rats with short bowel syndrome complicated with ulcerative colitis}, keyword = {BPC 157, short bowel syndrome, ulcerative colitis}, publisher = {Polish Physiological Society}, publisherplace = {Split, Hrvatska} }
@article{article, editor = {Sikiri\'{c}, P.}, year = {2009}, pages = {83-83}, keywords = {BPC 157, short bowel syndrome, ulcerative colitis}, title = {Safe anti-ulcer peptide, (PL-14736, Pliva) in trial for inflammatory bowel disease, stable gastric pentadecapeptide BPC 157 can cure rats with short bowel syndrome complicated with ulcerative colitis}, keyword = {BPC 157, short bowel syndrome, ulcerative colitis}, publisher = {Polish Physiological Society}, publisherplace = {Split, Hrvatska} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE





Contrast
Increase Font
Decrease Font
Dyslexic Font